STAR1,211.00

Strides Pharma Science Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersSPARCSUPRIYASHILPAMEDTHYROCARERUBICONVIYASHYATHARTHPARKHOSPSMcap ₹11,162 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations4,051.14,565.34,858.75,004.4
Other Income39.758.7150.7147.0
Total Income4,090.84,624.15,009.45,151.4
Expenses
+ Cost of Materials Consumed1,341.11,475.91,558.91,713.1
+ Purchases of Stock-in-Trade283.4688.1361.5407.0
+ Changes in Inventories15.9-184.038.3-110.4
+ Employee Benefit Expense751.1862.8929.0946.4
+ Finance Costs314.4248.9178.5171.6
+ Depreciation & Amortisation220.7192.3202.4209.9
+ Other Expenses916.2919.81,045.71,111.3
Total Expenses3,843.04,203.64,314.34,448.9
EBITDA743.3802.8925.3937.0
EBIT522.6610.6722.9727.1
Profit
PBT before Exceptional Items247.8420.4695.1702.5
+ Exceptional Items-189.064.7-26.844.7
Pretax Income58.8485.1668.2747.2
+ Current Tax37.346.977.996.0
+ Deferred Tax-5.730.616.315.8
Tax Expense31.677.594.2111.8
+ Share of Associates & JVs-175.71.80.5-0.9
Net Income-94.33,597.5574.5634.4
+ Net Income — Continuing Ops27.2407.6574.1635.3
+ Net Income — Discontinued Ops54.23,188.10.00.0
+ Other Comprehensive Income-54.7149.844.034.3
Total Comprehensive Income-149.03,747.3618.5668.7
Net Income to Common-70.63,593.5556.2613.5
Minority Interest-23.74.118.320.9
Per Share
Basic EPS-7.76390.5460.3466.56
Diluted EPS-7.77390.5060.3466.55
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax54.23,188.10.00.0
Other Comprehensive Income — detail
+ Other Comprehensive Income149.844.034.3
+ Items NOT to be Reclassified to P&L-57.9185.0-46.7-96.5
+ Tax on Items NOT to be Reclassified-2.046.1-9.1-21.7
+ Tax on Items NOT to be Reclassified — alt tag-1.9
+ Items to be Reclassified to P&L3.011.861.5100.1
+ Tax on Items to be Reclassified0.8-20.1-9.0
+ Tax on Items to be Reclassified — alt tag1.8
Comprehensive Income — Owners of Parent-124.73,740.5597.7517.3
Comprehensive Income — Non-controlling Interests-24.36.820.819.9
Per Share — as-filed variants
Basic EPS — Continuing Operations-13.7244.0560.3466.56
Diluted EPS — Continuing Operations-13.7244.0560.3466.55
Basic EPS — Discontinued Operations5.96346.490.000.00
Diluted EPS — Discontinued Operations5.95346.450.000.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit2,410.62,585.42,900.02,994.7
Gross Margin %59.5056.6359.6959.84
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)247.8420.4695.1702.5
− Exceptional Items (reconciliation)-189.064.7-26.844.7
Net Income Adj (tax-effected)-6.83,543.2597.6596.4
EPS Adj-0.56384.6462.7662.57
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital91.992.292.292.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.